{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:39:05Z","timestamp":1789205945003,"version":"build-2803163510"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thekneejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Knee"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.knee.2025.08.007","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:48:45Z","timestamp":1755650925000},"page":"77-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["GLP-1 agonists are protective against postoperative complications following total knee arthroplasty"],"prefix":"10.1016","volume":"57","author":[{"given":"Rachel","family":"Ranson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip M.","family":"Parel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kirkland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson W.","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan C.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.knee.2025.08.007_b0005","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.2337\/dc23-S011","article-title":"Chronic kidney disease and risk management: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabet Care"},{"issue":"Suppl 1","key":"10.1016\/j.knee.2025.08.007_b0010","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.2337\/dc19-S008","article-title":"8. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2019","volume":"42","author":"American Diabetes Association","year":"2019","journal-title":"Diabet Care"},{"issue":"344","key":"10.1016\/j.knee.2025.08.007_b0015","article-title":"Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials","volume":"10","author":"Vilsb\u00f8ll","year":"2012","journal-title":"BMJ"},{"issue":"3\u20134","key":"10.1016\/j.knee.2025.08.007_b0020","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1900\/RDS.2014.11.202","article-title":"Adverse effects of GLP-1 receptor agonists","volume":"11","author":"Filippatos","year":"2014","journal-title":"Rev Diabet Stud"},{"issue":"1","key":"10.1016\/j.knee.2025.08.007_b0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11999-014-3668-9","article-title":"The John Insall Award: morbid obesity independently impacts complications, mortality, and resource use after TKA","volume":"473","author":"D'Apuzzo","year":"2015","journal-title":"Clin Orthop Relat Res"},{"issue":"13","key":"10.1016\/j.knee.2025.08.007_b0030","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.3390\/jcm11133752","article-title":"Prevalence and risk of infection in patients with diabetes following primary total knee arthroplasty: a global systematic review and meta-analysis of 120,754 knees","volume":"11","author":"Ahmad","year":"2022","journal-title":"J Clin Med"},{"issue":"11","key":"10.1016\/j.knee.2025.08.007_b0035","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.arth.2023.05.071","article-title":"Does semaglutide use decrease complications and costs following total knee arthroplasty?","volume":"38","author":"Magruder","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2025.08.007_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.arth.2024.05.079","article-title":"Decreased risk of readmission and complications with preoperative GLP-1 analog use in patients undergoing primary total joint arthroplasty","author":"Buddhiraju","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2025.08.007_b0045","unstructured":"Fleeter T. How will the rising use of GLP-1 medications impact patients and orthopaedics? AAOS Now. 2024. Retrieved September 28, 2024, from https:\/\/www.aaos.org\/aaosnow\/2024\/jun\/clinical\/clinical01."},{"issue":"9","key":"10.1016\/j.knee.2025.08.007_b0050","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.arth.2024.04.048","article-title":"Chronic oral corticosteroid use and 10-year incidence of major complications following total knee arthroplasty","volume":"39","author":"Haft","year":"2024","journal-title":"J Arthroplasty"},{"issue":"9","key":"10.1016\/j.knee.2025.08.007_b0055","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.arth.2023.03.070","article-title":"10-year cumulative incidence and indications for revision total knee arthroplasty among patients who have sickle cell disease","volume":"38","author":"Parel","year":"2023","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.knee.2025.08.007_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jse.2024.03.027","article-title":"Reverse total shoulder arthroplasty within 6 weeks of proximal humerus fracture is associated with the lowest risk of revision","author":"Parel","year":"2024","journal-title":"J Shoulder Elbow Surg"},{"issue":"2","key":"10.1016\/j.knee.2025.08.007_b0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0033-1341407","article-title":"The effects of obesity and morbid obesity on outcomes in TKA","volume":"26","author":"McElroy","year":"2013","journal-title":"J Knee Surg"},{"issue":"3","key":"10.1016\/j.knee.2025.08.007_b0070","doi-asserted-by":"crossref","DOI":"10.1177\/23094990211061209","article-title":"The effect of body mass index on blood loss and complications in simultaneous bilateral total hip arthroplasty: a multicenter retrospective study","volume":"29","author":"Cao","year":"2021","journal-title":"J Orthop Surg"},{"issue":"3","key":"10.1016\/j.knee.2025.08.007_b0075","first-page":"198","article-title":"Do obese patients bleed more? A prospective study of blood loss at total hip replacement","volume":"81","author":"Bowditch","year":"1999","journal-title":"Ann R Coll Surg Engl"},{"issue":"5","key":"10.1016\/j.knee.2025.08.007_b0080","doi-asserted-by":"crossref","first-page":"818","DOI":"10.4239\/wjd.v15.i5.818","article-title":"Cardioprotective effects of glucagon-like peptide 1 receptor agonists in heart failure: Myth or truth?","volume":"15","author":"Nesti","year":"2024","journal-title":"World J Diabet"},{"issue":"9","key":"10.1016\/j.knee.2025.08.007_b0085","article-title":"A meta-analysis evaluating indirectly GLP-1 receptor agonists and arrhythmias in patients with type 2 diabetes and myocardial infarction","volume":"5","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.knee.2025.08.007_b0090","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.3390\/jcm10112419","article-title":"Effects of hyperglycemia and diabetes mellitus on coagulation and hemostasis","volume":"10","author":"Li","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.knee.2025.08.007_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2023.114093","article-title":"The role of glucagon-like peptide-1 (GLP-1) in fluid and food intakes in vasopressin-deficient Brattleboro rats","volume":"262","author":"Brakey","year":"2023","journal-title":"Physiol Behav"},{"issue":"6","key":"10.1016\/j.knee.2025.08.007_b0100","doi-asserted-by":"crossref","first-page":"R1755","DOI":"10.1152\/ajpregu.00472.2011","article-title":"Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake","volume":"301","author":"McKay","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"}],"container-title":["The Knee"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968016025002108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968016025002108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:24:07Z","timestamp":1766517847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968016025002108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":20,"alternative-id":["S0968016025002108"],"URL":"https:\/\/doi.org\/10.1016\/j.knee.2025.08.007","relation":{},"ISSN":["0968-0160"],"issn-type":[{"value":"0968-0160","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 agonists are protective against postoperative complications following total knee arthroplasty","name":"articletitle","label":"Article Title"},{"value":"The Knee","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.knee.2025.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}